News & Reports

Have some news you want to share with the Oregon Bio community?  Fill out our submission form.

Northwest bio and med tech companies go Beyond the Bay

Last week, Oregon Bioscience Association teamed with Catalyze to go ‘Beyond the Bay,’ hosting the Beyond The Bay Pacific NW Networking Reception at the 38th JP Morgan Healthcare Conference in San Francisco.

Hundreds of attendees joined Northwest attending companies in the biotechnology, digital, medical device and pharmaceutical sectors. “It was a very big week for us in the Bay Area with this key opportunity to showcase bio and tech in the Pacific Northwest on a world stage,” […]

January 21, 2020 |

We’re taking our show on the road – with you

Join your Northwest bio peers and colleagues at the 2020 BIO International Convention, happening June 8-11 in San Diego. BIO’s annual exhibition and conference is the premier bioscience showcase and professional development event for tens of thousands life science company executives, investors and researchers.  Oregon and Washington are teaming up to bring the Pacific Northwest Pavilion to the exhibition hall floor, providing a targeted space for focused partnering meetings and a showcase for all of the activity […]

AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein Printing™ Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

VANCOUVER, Wash., Jan. 13, 2020 /PRNewswire/ — AbSci, the Protein Printing™ company with a best-in-class E. coli cell line for rapid and low-cost biomanufacturing of complex biotherapeutics, today announced the completion of a $10.4M Series D financing led by KBI Biopharma and JSR Life Sciences. Existing investors Phoenix Venture Partners, Oregon Venture Fund, WRF Capital, and Columbia Ventures Corporation also participated in the financing. The financing also includes $5M in term debt. The proceeds from the financing will be used for expansion of AbSci facilities and team in order to […]

January 16, 2020 |

OREGON BIO AND CATALYZE TEAM UP TO HOST NORTHWEST RECEPTION AT PRESTIGIOUS JP MORGAN CONFERENCE

(Portland, Ore.)  – The Pacific Northwest’s bioscience and digital health sector will be on display ‘Beyond the Bay’ at the J.P. Morgan healthcare investor conference next week.

Oregon Bioscience Association and Catalyze are hosting the Beyond The Bay Pacific NW Networking Reception from 4-7 p.m. on January 14, 2020, at the 38th JP Morgan Healthcare Conference in San Francisco. The conference runs from Jan. 13-16. Northwest companies attending will include those in the biotechnology, digital, medical device […]

January 13, 2020 |

Oregon life sciences leaders celebrate repeal of medical device tax

By Elizabeth Hayes  – Staff Reporter, Portland Business Journal

Jan. 8, 2020

A tax on medical device sales died in December, and Oregon bioscience industry leaders couldn’t be more pleased.

“The fact it was finally repealed sends a strong signal,” said Juergen Lindner, general manager at Micro Systems Engineering, a division of Biotronik, which has its North American headquarters in Lake Oswego.

The 2.3 percent tax on revenue, which was part of the […]

January 8, 2020 |

News from National: Medical Device Tax Finally Fully Repealed

In late December, congressional leadership reached bipartisan agreement on the end-of-year federal  spending package/bill and Dec. 21 President Trump signed it, which included full repeal of the medical device tax.

AdvaMed/SMTA added it’s time to “celebrate this huge win for the patients served by medtech innovation, and for getting patients the life-saving and life-improving medical technologies they need.”

According to Forbes.com, the 2.3% tax on medical device sales that is part of the Affordable Care […]

January 7, 2020 |

Biotech Summit Helps Set Course for 2020

Oregon Bioscience Association held the Biotech Summit on Oct. 28, 2019, aiming to create substantive economic development and policy goals for the coming years.  Oregon’s bioscience industry, comprising more than 800 companies, labs, research institutions and supply chain firms, promotes public policies fostering job creation, company recruitment, innovation and health access, Oregon Bio’s advocacy platform comprises four key elements: 

Accelerate and Improve Oregon’s Environment for Biotechnology and Life Science Companies 
Foster Collaboration Between Industry Experts and Government Leaders 
Support Expansion of a Highly-Skilled, Diverse Workforce 
Maintain Access and Encourage Adherence to Health […]

Oregon Bio Members Invited to JPM Reception

We are very excited to share that Oregon Bioscience Association and Catalyze are hosting an invitation-only Pacific NW Networking Reception from 4-7 p.m. on Jan. 14, 2020, at the 38th JP Morgan Healthcare Conference in San Francisco.

While the JP Morgan Conference is itself an exclusive event, it has spawned a global hub for healthcare investment. Including our reception, there are many opportunities to connect, network, hold meetings and create partnerships through the many ancillary events that week […]

December 19, 2019 |

CAI Announces Succession Plan: Mike Martin is CAI’s Next CEO

CAI announced that Mike Martin, VP Strategy and Development, has been named to succeed Bob Chew in January 2022.  Mike Martin will assume the role of CEO in January 2022, while Bob Chew will continue to serve as Chairman of the Board.  Mike will work with Bob and the Board of Directors to lead strategy and direction for CAI.

Mike joined CAI in 2018, diving right in leading our program and project management vertical market.  He gained immediate exposure to our […]

December 13, 2019 |

Be Known by the Company You Keep: Your Preview to Oregon Bio’s 2020 Sponsor Prospectus

As you are preparing your 2020 marketing budget, we encourage you to consider Oregon Bioscience Association in your vision for the new year. Oregon Bio, Oregon and SW Washington’s bioscience organization, is planning numerous events around the region.

Supporting Oregon Bio events is an extremely effective way to gain brand visibility and make valuable connections, while also supporting our region’s growing bioscience community. Event sponsorship benefits often include marketing space at events, logo presence, complimentary event registrations, and more. You can […]

Epizyme won accelerated FDA approval Thursday for a drug developed to treat the rare cancer epithelioid sarcoma (ES). The regulatory decision for the Epizyme (NASDAQ: EPZM) drug, tazemetostat (Tazveri [...]

David Moller has joined Poxel as its chief scientific officer, the same position he held most recently at Sigilon Therapeutics. Moller's experience also includes research and development roles at [...]

Gene therapy developer Krystal Biotech (NASDAQ: KRYS) has appointed Jennifer Chien to the newly created role of chief commercial officer. She comes to Pittsburgh-based Krystal from the Genzyme unit of [...]

BEIJING (AP) -- China is swiftly building a hospital dedicated to treating patients infected with a new virus that has killed 26 people, sickened hundreds and prompted unprecedented lockdowns of citie [...]

Welcome to Thursday's Overnight Health Care.The novel coronavirus outbreak is not a public health emergency yet, Blue Cross wants to lower drug prices, and a House Democrat wants FDA to step up o [...]

The FDA approved a new, tiny pacemaker from Medtronic that does not require the wiring of separate electrodes between the implant and the heart. Less than one-tenth the size of traditional pacemakers [...]

On the heels of a $2.7 billion tie-up with BeiGene in China, Amgen is now on track to take full control of a Japanese joint venture with Astellas, as the Big Biotech bets more on the rapidly growing A [...]